Zhao Baoyu, Zhang Zhenzhan, Mo Debin, Lu Yiming, Hu Yanfeng, Yu Jiang, Liu Hao, Li Guoxin
Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Department of General Surgery, Shanxi Provincial People's Hospital, Taiyuan, China.
Front Oncol. 2019 Jan 21;8:639. doi: 10.3389/fonc.2018.00639. eCollection 2018.
The optimal extent of gastrectomy and lymphadenectomy for esophagogastric junction (EGJ) cancer is controversial. Our study aimed to compare the long-term survival of transhiatal proximal gastrectomy with extended periproximal lymphadenectomy (THPG with EPL) and transhiatal total gastrectomy with complete perigastric lymphadenectomy (THTG with CPL) for patients with the stomach-predominant EGJ cancer. Between January 2004, and August 2015, 306 patients with Siewert II tumors were divided into the THTG group ( = 148) and the THPG group ( = 158). Their long-term survival was compared according to Nishi's classification. The Kaplan-Meier method and Cox proportional hazards models were used for survival analysis. There were no significant differences between the two groups in the distribution of age, gender, tumor size or Nishi's type ( > 0.05). However, a significant difference was observed in terms of pathological tumor stage ( < 0.05). The 5-year overall survival rates were 62.0% in the THPG group and 59.5% in the THTG group. The hazard ratio for death was 0.455 (95% CI, 0.337 to 0.613; log-rank < 0.001). Type GE/E = G showed a worse prognosis compared with Type G ( < 0.05). Subgroup analysis stratified by Nishi's classification, Stage IA-IIB and IIIA, and tumor size ≤ 30 mm indicated significant survival advantages for the THPG group ( < 0.05). However, this analysis failed to show a survival benefit in Stage IIIB ( > 0.05). Nishi's classification is an effective method to clarify the subdivision of Siewert II tumors with a diameter ≤ 40 mm above or below the EGJ. THPG with EPL is an optimal procedure for the patients with the stomach-predominant EGJ tumors ≤30 mm in diameter and in Stage IA-IIIA. For more advanced and larger EGJ tumors, further studies are required to confirm the necessity of THTG with CPL.
食管胃交界(EGJ)癌的最佳胃切除范围和淋巴结清扫范围存在争议。我们的研究旨在比较经胸近端胃切除术联合扩大近端周围淋巴结清扫术(THPG联合EPL)和经胸全胃切除术联合完整胃周淋巴结清扫术(THTG联合CPL)治疗以胃为主的EGJ癌患者的长期生存率。2004年1月至2015年8月期间,306例Siewert II型肿瘤患者被分为THTG组(n = 148)和THPG组(n = 158)。根据Nishi分类比较两组的长期生存率。采用Kaplan-Meier法和Cox比例风险模型进行生存分析。两组在年龄、性别、肿瘤大小或Nishi类型分布上无显著差异(P>0.05)。然而,在病理肿瘤分期方面观察到显著差异(P<0.05)。THPG组的5年总生存率为62.0%,THTG组为59.5%。死亡风险比为0.455(95%CI,0.337至0.613;对数秩检验P<0.001)。GE/E = G型与G型相比预后较差(P<0.05)。按Nishi分类、IA-IIB期和IIIA期以及肿瘤大小≤30 mm进行亚组分析,结果显示THPG组具有显著的生存优势(P<0.05)。然而,该分析未能显示IIIB期有生存获益(P>0.05)。Nishi分类是一种有效的方法,可明确EGJ上方或下方直径≤40 mm的Siewert II型肿瘤的细分情况。THPG联合EPL是治疗直径≤30 mm且处于IA-IIIA期以胃为主的EGJ肿瘤患者的最佳手术方式。对于更晚期和更大的EGJ肿瘤,需要进一步研究以证实THTG联合CPL的必要性。